nq93017.htm - Generated by SEC Publisher for SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF
REGISTERED MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number: 811-00041

GENERAL AMERICAN INVESTORS COMPANY, INC.
(Exact name of registrant as specified in charter)

100 Park Avenue, 35th Floor, New York, NY 10017
(Address of principal executive offices)(Zip code)

Eugene S. Stark
General American Investors Company, Inc.
100 Park Avenue, 35th Floor,
New York, NY 10017
(Name and address of agent for service)

Registrant's telephone number, including area code: 212-916-8400

Date of fiscal year end: December 31

Date of reporting period: September 30, 2017



            Value
    Shares COMMON STOCKS     (note 1a)
CONSUMER   AUTOMOBILES AND COMPONENTS (1.3%)      
DISCRETIONARY   1,264,063   Ford Motor Company (Cost $16,174,723) $15,130,834
(14.4%)          
    MEDIA (1.4%)        
    15,000   Charter Communications, Inc. (a)     5,451,300
    607,845   Regal Entertainment Group     9,725,520
        (Cost $17,124,360)   15,176,820
    RETAILING (11.7%)      
    20,000   Amazon.com, Inc. (a)     19,227,000
    335,779   Liberty Expedia Holdings, Inc. (a)     17,833,223
    321,599   Liberty Interactive Corporation, Series A (a)   18,508,022
    345,000   Macy’s, Inc.     7,527,900
    919,768   The TJX Companies, Inc.     67,814,495
        (Cost $56,853,719)   130,910,640
        (Cost $90,152,802)   161,218,294
  
CONSUMER   FOOD, BEVERAGE AND TOBACCO (11.2%)      
STAPLES   220,000   Danone (France)     17,250,094
(15.3%) 93,210   Diageo plc ADR (United Kingdom)     12,315,837
    450,000   Nestle S.A. (Switzerland)     37,681,983
    195,000   PepsiCo, Inc.     21,728,850
    625,000   Unilever N.V. (Netherlands/United Kingdom)   36,948,288
        (Cost $60,723,128)   125,925,052
    FOOD AND STAPLES RETAILING (4.1%)      
    118,781   Costco Wholesale Corporation     19,514,531
    130,000   CVS Health Corporation     10,571,600
    200,000   Wal-Mart Stores, Inc.     15,628,000
        (Cost $30,134,977)   45,714,131
        (Cost $90,858,105)   171,639,183
  
ENERGY   173,000   Anadarko Petroleum Corporation     8,451,050
(5.2%) 1,140,947   Cameco Corporation (Canada)     11,032,957
    1,200,000   Ensco plc - Class A (United Kingdom)     7,164,000
    3,830,440   Gulf Coast Ultra Deep Royalty Trust (a)     172,370
    420,000   Halliburton Company     19,332,600
    1,721,159   Helix Energy Solutions Group, Inc. (a)     12,719,365
        (Cost $48,162,160)   58,872,342
 
FINANCIALS   BANKS (1.6%)        
(20.0%) 110,000   M&T Bank Corporation (Cost $560,176)   17,714,400
    DIVERSIFIED FINANCIALS (4.8%)      
    165,000   American Express Company     14,925,900
    205,000   JPMorgan Chase & Co.     19,579,550
    390,000   Nelnet, Inc.     19,695,000
        (Cost $15,221,881)   54,200,450
    INSURANCE (13.6%)      
    154,552   Aon plc (United Kingdom)     22,580,047
    400,000   Arch Capital Group Ltd. (a) (Bermuda)     39,400,000
    245,000   Axis Capital Holdings Limited (Bermuda)   14,040,950
    110   Berkshire Hathaway Inc. Class A (a) (b)     30,221,400
    110,000   Everest Re Group, Ltd. (Bermuda)     25,122,900
    400,000   MetLife, Inc.     20,780,000
        (Cost $38,059,971)   152,145,297
        (Cost $53,842,028)   224,060,147

 


 
 Item 1.  Statement of Investments

            Value
    Shares COMMON STOCKS (continued)     (note 1a)
  PHARMACEUTICALS, BIOTECHNOLOGY AND LIFE SCIENCES      
HEALTH CARE   867,600 Arantana Therapeutics, Inc. (a)   $5,318,388
(9.4%)   155,000 Celgene Corporation (a)     22,602,100
463,600 Gilead Sciences, Inc.     37,560,872
    284,942 Intra-Cellular Therapies, Inc. (a)     4,496,385
    200,191 Merck & Co., Inc.     12,818,230
    347,213 Paratek Pharmaceuticals, Inc. (a)     8,715,046
    380,808 Pfizer Inc.     13,594,846
    237,504 Repros Therapeutics Inc. (a)     76,001
        (Cost $47,765,358)   105,181,868
 
   CAPITAL GOODS (6.3%)      
INDUSTRIALS   189,131 Eaton Corporation plc (Ireland)     14,523,369
(10.9%)   870,000 General Electric Company     21,036,600
    315,000 Johnson Controls International plc     12,691,350
    190,000 United Technologies Corporation     22,055,200
        (Cost $60,675,918)   70,306,519
  COMMERCIAL AND PROFESSIONAL SERVICES (4.6%)      
    787,800 Republic Services, Inc. (Cost $11,167,520)   52,042,068
        (Cost $71,843,438)   122,348,587
   
  SEMICONDUCTORS AND SEMICONDUCTOR EQUIPMENT (4.0%)      
INFORMATION   260,000 Applied Materials, Inc.     13,543,400
TECHNOLOGY   185,850 ASML Holding N.V. (Netherlands)     31,817,520
(22.9%)            
    (Cost $11,269,875)   45,360,920
  SOFTWARE AND SERVICES (11.7%)      
    30,500 Alphabet Inc. (a)     29,252,855
    755,000 eBay Inc. (a)     29,037,300
    605,686 Microsoft Corporation     45,117,550
    380,328 Oracle Corporation     18,388,859
    53,170 Tyler Technologies, Inc. (a)     9,268,594
        (Cost $88,192,428)   131,065,158
  TECHNOLOGY HARDWARE AND EQUIPMENT (7.2%)      
    104,000 Apple Inc.     16,028,480
    790,000 Cisco Systems, Inc.     26,567,700
    301,200 QUALCOMM Incorporated     15,614,208
    170,709 Universal Display Corporation     21,995,855
        (Cost $35,927,580)   80,206,243
        (Cost $135,389,883)   256,632,321
 
 
MISCELLANEOUS     Other (c) (Cost $22,065,897)   22,237,159
(2.0%)            
TELECOMMUNICATION   521,252 Vodafone Group plc ADR (United Kingdom) (Cost $16,865,092)   14,834,832
SERVICES            
(1.3%)          
      TOTAL COMMON STOCKS (101.4%) (Cost $576,944,763)   1,137,024,733
 
    Warrant WARRANT (a)      
TECHNOLOGY   281,409 Applied DNA Sciences, Inc. (Cost $2,814)   196,986
HARDWARE AND            
EQUIPMENT            
(0.0%)          

 


 


        Value
Shares SHORT-TERM SECURITY AND OTHER ASSETS   (note 1a)
184,423,860 State Street Institutional Treasury Plus Money Market Fund,    
  Trust Class, 0.86% (d) (16.4%) (Cost $184,423,860) $184,423,860
TOTAL INVESTMENTS (e) (117.8%) (Cost $761,371,437)   1,321,645,579
Liabilities in excess of receivables and other assets (-0.9%)     (9,865,817)
        1,311,779,762
PREFERRED STOCK (-16.9%)       (190,117,175)
NET ASSETS APPLICABLE TO COMMON STOCK (100%)   $1,121,662,587

 

ADR - American Depository Receipt
(a) Non-income producing security.
(b) Security is held as collateral for options written.
(c) Securities which have been held for less than one year, not previously disclosed, and not restricted.
(d) 7 day yield.
(e) At September 30, 2017, the cost of investments for Federal income tax purposes was $761,578,730; aggregate gross unrealized appreciation
was $582,121,890; aggregate gross unrealized depreciation was $22,055,041; and net unrealized appreciation was $560,066,849.


NOTES TO FINANCIAL STATEMENTS (Unaudited)
General American Investors

General American Investors Company, Inc. (the "Company"), established in 1927, is registered under the Investment Company Act of 1940 as a closed-end, diversified management investment company. It is internally managed by its officers under the direction of the Board of Directors.

1. SECURITY VALUATION

Equity securities traded on a national securities exchange are valued at the last reported sales price on the last business day of the period. Equity securities reported on the NASDAQ national market are valued at the official closing price on that day. Listed and NASDAQ equity securities for which no sales are reported on that day and other securities traded in the over-the-counter market are valued at the last bid price (asked price for options written) on the valuation date. Equity securities traded primarily in foreign markets are valued at the closing price of such securities on their respective exchanges or markets. Corporate debt securities, domestic and foreign, are generally traded in the over-the-counter market rather than on a securities exchange. The Company utilizes the latest bid prices provided by independent dealers and information with respect to transactions in such securities to assist in determining current market value. If, after the close of foreign markets, conditions change significantly, the price of certain foreign securities may be adjusted to reflect fair value as of the time of the valuation of the portfolio. Investments in money market funds are valued at their net asset value. Special holdings (restricted securities) and other securities for which quotations are not readily available are valued at fair value determined in good faith pursuant to specific procedures appropriate to each security as established by and under the general supervision of the Board of Directors. The determination of fair value involves subjective judgments. As a result, using fair value to price a security may result in a price materially different from the price used by other investors or the price that may be realized upon the actual sale of the security.

2. OPTIONS

The Company may purchase and write (sell) put and call options. The Company typically purchases put options or writes call options to hedge the value of portfolio investments while it typically purchases call options and writes put options to obtain equity market exposure under specified circumstances. The risk associated with purchasing an option is that the Company pays a premium whether or not the option is exercised. Additionally, the Company bears the risk of loss of the premium and a change in market value should the counterparty not perform under the contract. Put and call options purchased are accounted for in the same manner as portfolio securities. Premiums received from writing options are reported as a liability on the Statement of Assets and Liabilities. Those that expire unexercised are treated by the Company on the expiration date as realized gains on written option transactions in the Statement of Operations. The difference between the premium received and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss on written option transactions in the Statement of Operations. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security in determining whether the Company has realized a gain or loss on investments in the Statement of Operations. If a put option is exercised, the premium reduces the cost basis for the securities purchased by the Company and is parenthetically disclosed under cost of investments on the Statement of Assets and Liabilities. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option.


 

3. FAIR VALUE MEASUREMENTS

Various data inputs are used in determining the value of the Company’s investments. These inputs are summarized in a hierarchy consisting of the three broad levels listed below:

     Level 1 - quoted prices in active markets for identical securities (including money market funds which are valued using amortized cost and which transact at net asset value, typically $1 per share),

     Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, credit risk, etc.), and

     Level 3 - significant unobservable inputs (including the Company’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following is a summary of the inputs used to value the Company’s net assets as of September 30, 2017:

Assets   Level 1 Level 2 Level 3   Total
Common Stocks $1,137,024,733 - - $1,137,024,733
Warrant   196,986 - -   196,986
Money Market   184,423,860 - -   184,423,860
Total $1,321,645,579 - - $1,321,645,579

 


 

ITEM 2. CONTROLS AND PROCEDURES.

Conclusions of principal officers concerning controls and procedures

(a) As of September 30, 2017, an evaluation was performed under the supervision and with the participation of the officers of General American Investors Company, Inc. (the "Registrant"), including the principal executive officer ("PEO") and principal financial officer ("PFO"), of the effectiveness of the Registrant's disclosure controls and procedures. Based on that evaluation, the Registrant's officers, including the PEO and PFO, concluded that, as of September 30, 2017, the Registrant's disclosure controls and procedures were reasonably designed so as to ensure: (1) that information required to be disclosed by the Registrant on Form N-Q is recorded, processed, summarized and reported within the time periods specified by the rules and forms of the Securities and Exchange Commission; and (2) that material information relating to the Registrant is made known to the PEO and PFO as appropriate to allow timely decisions regarding required disclosure.

(b) There have been no significant changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940 (17 CFR 270.30a-3(d)) that occurred during the Registrant's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.


 

ITEM 3. EXHIBITS.

The certifications of the principal executive officer and principal financial officer pursuant to Rule 30a-2(a)under the Investment Company Act of 1940 are attached hereto as Exhibit 99 CERT.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

General American Investors Company, Inc.

By: /s/ Eugene S. Stark
Eugene S. Stark
Vice-President, Administration

Date: October 27, 2017

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By: /s/ Jeffrey W. Priest
Jeffrey W. Priest
President and Chief Executive Officer
(Principal Executive Officer)

Date: October 27, 2017

By: /s/ Eugene S. Stark
Eugene S. Stark
Vice-President, Administration
(Principal Financial Officer)

Date: October 27, 2017